NEW YORK, July 25: Amgen Inc, the world’s largest biotechnology company, has lined up Bank of America Corp, JPMorgan Chase & Co and Barclays Plc
To finance a potential deal for Onyx Pharmaceuticals Inc, according to three people familiar with the matter. Thousand Oaks, California-based Amgen, whose preliminary $120 per-share offer for Onyx was rejected by the company’s board last month, is still keen to buy the cancer drugmaker and waiting to see if a higher competing offer will materialize, the people said on Wednesday. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel